Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab

Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab

Bibliographic Details
Main Authors: Freeman, C L, Dixon, M, Houghton, R, Kreuzer, K-A, Fingerle-Rowson, G, Herling, M, Humphrey, K, Böttcher, S, de Costa, C S, Iglesias, V, Stilgenbauer, S, Gribben, J, Hallek, M, Goede, V
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/

Similar Items